Litigation Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2017)
✉ Email this page to a colleague
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-08 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-04-18 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Cathy L. Waldor |
| Parties | PROGENICS PHARMACEUTICALS, INC. | ||
| Patents | 8,420,663; 8,524,276; 8,956,651; 9,180,125; 9,314,461; 9,492,445; 9,724,343 | ||
| Attorneys | JASON B. LATTIMORE | ||
| Firms | Law Office of Jason B. Lattimore, Esq. | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LABORATORIES FL, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for VALEANT PHARMACEUTICALS INTERNATIONAL, INC. v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-12-07 | 1 | “the Orange Book”), together with U.S. Patent Nos. 8,420,663, 8,524,276, 8,956,651, 9,180,125, and 9,…United States Patent Nos. 9,724,343 (“the ’343 patent”) and 9,492,445 (“the ’445 patent”) arising under… THE PATENT IN SUIT 24. The U.S. Patent and Trademark Office (“PTO”…PTO”) issued the ’445 patent on November 15, 2016. The ’445 patent claims, inter alia, compositions of …the ’445 patent and have the right to sue for infringement thereof. A copy of the ’445 patent is attached | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
